Browse the evidence

Excess visceral adipose tissue is a primary driver of cardiometabolic risk, independent of total body fat or BMI, by causing insulin resistance, atherogenic dyslipidemia, and inflammation.

Do not rely on BMI alone to assess your health risk. If you have a large waist circumference, especially combined with high triglycerides, you may have dangerous visceral fat even if your weight is normal. Prioritize reducing abdominal fat through lifestyle changes, as this specific fat type drives heart disease and diabetes risk more than total body weight does.

High body-mass index (BMI) is a significant metabolic risk factor with increasing exposure rates (1.8% annually) and a 15.7% rise in age-standardized DALY rates from 2000 to 2021.

High BMI is a significant metabolic risk factor with increasing exposure rates. Addressing high BMI is crucial for long-term health.

Prebiotic fibers (inulin, FOS, GOS) selectively stimulate beneficial gut bacteria (Bifidobacteria, Lactobacilli) and increase Short Chain Fatty Acid (SCFA) production, particularly butyrate.

Include prebiotic fibers like inulin, FOS, or GOS in your diet to support gut health. These fibers feed beneficial bacteria and produce butyrate, which is crucial for colon health and energy regulation.

Restricting sleep to 4-5 hours per night for seven consecutive nights causes cumulative, escalating deficits in subjective sleepiness, mood disturbance, and psychomotor vigilance performance (specifically increased lapse frequency and duration).

If you restrict your sleep to 4-5 hours a night for a week, your ability to stay alert and perform tasks will get worse every day, even if you don't feel significantly more tired. Your reaction times will slow, and you will make more mistakes (lapses). This is a cumulative effect that builds up over the week.

Maintaining a body weight 10% or more below one's usual set point triggers a compensatory reduction in total energy expenditure (approx. 6 kcal/kg fat-free mass/day in non-obese, 8 kcal/kg/day in obese), creating a metabolic barrier to long-term weight maintenance.

If you lose 10% or more of your body weight, your body will automatically burn fewer calories per day (by about 6-8 kcal per kg of lean mass). To maintain this new weight, you must eat fewer calories than you did at your previous weight. Failing to reduce your food intake to match this new metabolic rate will result in weight regain.

Gaining 10% or more body weight triggers a compensatory increase in total energy expenditure (approx. 9 kcal/kg fat-free mass/day in non-obese, 8 kcal/kg/day in obese), which helps resist further weight gain.

If you gain 10% or more body weight, your body will automatically burn more calories per day (by about 8-9 kcal per kg of lean mass). This is a natural defense against obesity. However, this increase may not fully counteract the overeating that caused the gain, so conscious dietary management is still required.

In the pathogenesis of type 2 diabetes, defects in both insulin action (resistance) and insulin secretion (dysfunction) occur early during the transition from normal glucose tolerance to impaired glucose tolerance, and both must be targeted for effective intervention.

If you are at risk for type 2 diabetes (e.g., prediabetes), focusing solely on one aspect of metabolic health is likely insufficient. You must address both how your body uses insulin (resistance) and how well your pancreas produces it (secretion). This typically involves lifestyle interventions that improve sensitivity (like exercise and weight management) while also supporting pancreatic function (often through weight loss and reducing metabolic stress). Early intervention is critical because these defects worsen over time.

Obesity and PCO have a synergistic deleterious effect on glucose tolerance, leading to higher fasting and post-load glucose levels and increased basal hepatic glucose production compared to either condition alone.

For women with PCO who are also obese, the risk of developing type 2 diabetes is significantly higher than for obese women without PCO. This is due to a 'double hit' of hormonal resistance and excess weight. Aggressive management of both insulin sensitivity and weight is crucial.

Waist circumference is a superior and necessary clinical metric for assessing cardiometabolic risk compared to BMI alone, as it identifies visceral adiposity and high-risk phenotypes that BMI misses.

Stop relying solely on your weight or BMI. Measure your waist circumference. If it is high (≥88 cm for women, ≥102 cm for men), you are at higher risk for heart disease and diabetes, even if your weight is 'normal'. Use this measurement to guide lifestyle changes.

Exercise-based cardiac rehabilitation reduces hospital admissions in the short term (less than 12 months) but does not significantly reduce them in the medium to long term (12+ months).

Participating in cardiac rehab reduces your chances of being hospitalized in the first year after your heart event. However, this specific benefit may not persist beyond 12 months, so focus on the long-term mortality benefits which do continue.

Waist circumference is a better indicator of diabetes risk than Waist-to-Hip Ratio (WHR) because it has less measurement error and remains a significant predictor even after controlling for BMI, whereas WHR's association is largely explained by overall obesity.

Use waist circumference as a key health metric. A waist size >40 inches is associated with a significantly higher risk of diabetes. While BMI is important, waist circumference provides additional insight into abdominal fat, which is a strong predictor of diabetes risk. Measure your waist at the umbilicus and aim for a size well below 40 inches.

Intensive glycemic therapy (targeting near-normal glucose levels) significantly reduces the development and progression of microvascular complications (retinopathy, nephropathy, neuropathy) and cardiovascular disease in patients with type 1 diabetes compared to conventional therapy.

For people with Type 1 Diabetes, aiming for near-normal blood sugar levels through intensive insulin therapy (multiple daily injections or a pump) significantly reduces the risk of eye, kidney, nerve, and heart complications over the long term. While this approach increases the risk of low blood sugar events, it does not harm cognitive function or quality of life. The key is individualizing the regimen to fit your lifestyle while striving for lower HbA1c targets.

Bariatric surgery significantly reduces overall mortality, diabetes incidence, and cardiovascular events compared to usual care in obese patients over long-term follow-up.

For individuals with severe obesity (BMI >34-38 depending on sex), bariatric surgery is the most effective intervention for reducing long-term mortality and preventing type 2 diabetes and heart disease compared to lifestyle changes or medication alone. While surgery carries short-term risks, the long-term benefits in survival and disease prevention are substantial and sustained over decades.

Bariatric surgery induces high rates of type 2 diabetes remission and prevention, with effects persisting for at least 10-15 years, although some relapse occurs over time.

Bariatric surgery is highly effective at putting type 2 diabetes into remission, with most patients achieving remission within two years. While some patients may experience a return of diabetes over 10 years, the long-term risk of developing diabetes remains significantly lower than in non-surgical patients. Surgery is a powerful tool for diabetes management and prevention.

Management of osteoporosis should be guided by absolute fracture risk assessment rather than bone mineral density (BMD) alone, utilizing tools like CAROC or FRAX to stratify patients into low, moderate, or high risk categories.

Stop obsessing over your T-score alone. Ask your doctor for a 10-year fracture risk assessment (using tools like FRAX or CAROC). This calculation combines your age, sex, BMD, and lifestyle factors (like smoking or steroid use) to give you a real-world probability of breaking a bone, which determines if you need treatment.

Higher levels of total physical activity, regardless of intensity (including light activity), are associated with a substantially reduced risk of all-cause mortality in a non-linear dose-response pattern.

Focus on increasing your total daily movement volume rather than just high-intensity workouts. Aim for at least 10 hours of accelerometer wear time per day for 4+ days to capture accurate data, but practically, this means accumulating light activity (walking, standing) throughout the day. The biggest mortality risk reduction occurs with moderate increases in activity, particularly around 24 minutes of moderate-to-vigorous activity or 375 minutes of light activity per day. Do not neglect light activity; it is highly effective for longevity.

Diagnosing malnutrition requires the concurrent presence of at least one phenotypic criterion (weight loss, low BMI, or reduced muscle mass) and one etiologic criterion (reduced food intake/assimilation or disease burden/inflammation).

To diagnose malnutrition in a clinical setting, you must find evidence of physical changes (like weight loss, low BMI, or muscle loss) AND evidence of a cause (like reduced food intake or active inflammation). Neither alone is sufficient for a diagnosis.

Reduced muscle mass is a key phenotypic criterion for malnutrition, measurable by DXA, BIA, CT, MRI, or anthropometric proxies like calf/arm circumference.

Assess muscle mass using available tools like DXA, BIA, CT, or MRI. If these are unavailable, use anthropometric measures like calf or arm circumference, or functional assessments like grip strength.

Mood is the most sensitive measure of sleep deprivation, showing greater impairment than cognitive or motor performance, particularly under partial sleep deprivation conditions.

Monitor your mood closely when sleep-deprived. Mood deteriorates more severely than physical or cognitive output, serving as an early warning sign of sleep debt.

Obesity increases the risk of cardiovascular disease and hypertension through mechanisms involving increased visceral fat, insulin resistance, and altered sympathetic nervous system activity.

Managing your body weight, especially visceral fat, is crucial for heart health. Obesity increases your risk of cardiovascular disease and hypertension through multiple mechanisms, including insulin resistance and altered sympathetic nervous system activity. Losing weight can significantly reduce this risk.

Skeletal muscle hypertrophy is primarily regulated by the balance between protein synthesis and degradation, driven by the IGF1-Akt-mTOR pathway (positive regulator) and the myostatin-Smad2/3 pathway (negative regulator).

To build muscle, you need to stimulate the IGF1-Akt-mTOR pathway (via resistance training and adequate protein) while minimizing the inhibitory effects of myostatin. It's not just about eating enough to 'stop' loss; active signaling drives the growth.

Pharmacological treatment of hypertension significantly reduces major cardiovascular events, including heart failure, stroke, and mortality, regardless of baseline blood pressure levels.

If diagnosed with hypertension, adhere to prescribed pharmacological treatment. Fixed-dose combinations are often recommended to improve adherence and minimize side effects. The reduction in cardiovascular risk is substantial and consistent across different baseline risks.

Diagnosing malnutrition in adults requires the presence of at least one phenotypic criterion (non-volitional weight loss, low BMI, or reduced muscle mass) AND at least one etiologic criterion (reduced food intake/assimilation or disease burden/inflammation).

To diagnose malnutrition, you cannot rely on just one factor. You must find evidence of physical change (like weight loss, low BMI, or muscle loss) AND evidence of a cause (like poor eating or active inflammation/disease). Both must be present.

Television viewing time has a stronger association with mortality and type 2 diabetes risk than total sedentary time, with specific thresholds identified for increased risk.

Watching TV is particularly risky for your health. Try to limit TV time to under 3.5 hours a day, as this specific activity carries a higher risk of mortality and diabetes than other forms of sitting.